Eagle Health Investments LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001842545

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 23 positions · Total reported value $380.92M · Top-10 concentration 75.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 4 new · 4 cut · 9 exited

Active Share (vs S&P 500): 99.7% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2025 13F filing, Eagle Health Investments LP disclosed 23 equity positions with a combined reported value of $380.92M. The filing implies a focused portfolio: its ten largest positions account for 75.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were ARGX ($57.11M), INSM ($39.11M), NTRA ($32.78M). By sector, the heaviest allocations are Health Care 92.6%, Other 7.4%. Versus the prior quarter, allocation shifted toward Other (+1.5pp) and away from Health Care (-1.5pp).

Versus the prior quarter, Eagle Health Investments LP opened 4 new positions, trimmed 4 and fully exited 9, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q3 2025 were FTRE ($8.33M), CMPS ($5.36M), CNTA ($2.50M).

Of the 9 positions fully exited versus the prior quarter, the largest were DXCM ($23.90M), UNH ($19.00M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • FTRE FORTREA HLDGS INC COMMON STOCK · $8.33M
  • CMPS COMPASS PATHWAYS PLC · $5.36M
  • CNTA CENTESSA PHARMACEUTICALS PLC · $2.50M
  • ALKS ALKERMES PLC · $2.45M

Fully Exited (vs previous quarter)

  • DXCM DEXCOM INC · prev qtr: $23.90M
  • UNH UNITEDHEALTH GROUP INC · prev qtr: $19.00M

Insider Transactions (Form 4)

Latest Eagle Health Investments LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Eagle Health Investments LP, based in Greenwich, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 27 positions worth $603.31M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: GREENWICH, CT, United States
  • SEC registration: 801-121917 (status: Approved), registered 2021-07-29
  • Regulatory AUM (Form ADV): $605.26M as of 2026-03-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 27 positions · $603.31M reported value (Q2 2026)
  • Top 10 holdings = 66.1% of reported value
  • Largest position: ARGX (ARGENX SE FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS) at 11.8%
  • Average position size: $22.34M

Sector Tilt

  • Health Care 96.0%
  • Information Technology 2.5%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q2 2026: 5 new, 9 added, 4 reduced, 5 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.6%
Other 7.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 77.43K $57.11M 14.99%
14.99%
Hold
2 271.60K $39.11M 10.27%
10.27%
Reduce
3 203.66K $32.78M 8.61%
8.61%
Reduce
4 182.59K $31.95M 8.39%
8.39%
Reduce
5 322.26K $30.61M 8.03%
8.03%
Reduce
6 162.80K $22.85M 6.00%
6.00%
Reduce
7 697.00K $20.97M 5.50%
5.50%
Add
8 366.81K $19.87M 5.21%
5.21%
Hold
9 284.10K $17.75M 4.66%
4.66%
Add
10 270.95K $14.82M 3.89%
3.89%
Add
11 363.30K $13.53M 3.55%
3.55%
Add
12 259.30K $13.47M 3.54%
3.54%
Hold
13 308.43K $11.01M 2.89%
2.89%
Add
14 23.69K $10.80M 2.83%
2.83%
Reduce
15 226.40K $10.75M 2.82%
2.82%
Hold
16 246.23K $9.88M 2.60%
2.60%
Reduce
17 988.77K $8.33M 2.19%
2.19%
New
18 935.45K $5.36M 1.41%
1.41%
New
19 103.10K $2.50M 0.66%
0.66%
New
20 81.80K $2.45M 0.64%
0.64%
New
21 4.39K $1.96M 0.52%
0.52%
Hold
22 46.30K $1.68M 0.44%
0.44%
Hold
23 240.50K $1.37M 0.36%
0.36%
Hold

FAQ

What did Eagle Health Investments LP buy in 2025-Q3?

In its 2025-Q3 13F filing, Eagle Health Investments LP reported 23 equity positions worth $380.92M in aggregate; its largest disclosed positions were ARGX ($57.11M), INSM ($39.11M), NTRA ($32.78M).

How large is Eagle Health Investments LP's portfolio?

Eagle Health Investments LP reported $380.92M of long equity holdings across 23 positions as of 2025-Q3. Top-10 holdings account for 75.6% of reported value.

What is Eagle Health Investments LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/eagle-health-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →